Stock Quote
Ista Pharmaceuticals Inc (ISTA.W) (NASD ADF)
sector: Healthcare .
industry: Pharmaceuticals - Generic & Specialty ยท
View ISTA on other exchanges
$3.83
20 Nov 2009
-5.90%
$4.07
$3.83
200
$3.83
$3.83
$6.83
$0.40
0.76
126,599
ISTA.W
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Williams, Richard | Chairman of the Board | -- |
| Anido, Vicente | President, Chief Executive Officer, Director | 1,246,430 |
| Silvernail, Lauren | Chief Financial Officer, Vice President - Corporate Development, Chief Accounting Officer | 560,924 |
Profile
ISTA Pharmaceuticals, Inc. is an ophthalmic pharmaceutical company with products and product candidates for the treatment of inflammation, ocular pain, glaucoma, allergy and dry eye. The Company has three products available for sale in the United States: Xibrom, (bromfenac ophthalmic solution) for... Full Description
Company Address
Ista Pharmaceuticals Inc
15295 Alton Parkway
Irvine CA 92618
P: +1949.7886000
15295 Alton Parkway
Irvine CA 92618
P: +1949.7886000
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| Allergan, Inc. | $58.75 | +0.13 |
| Alcon, Inc. | $147.47 | +2.21 |
| Baxter International Inc. | $54.66 | +0.33 |
| ISTA.W | Industry | |
|---|---|---|
| P/E(TTM) | -- | 3.57 |
| P/S(TTM) | 1.33 | 0.57 |
| ROI(TTM) | -- | 1.86 |
| ROE(TTM) | -- | 2.51 |
| Consensus Recommendation | Outperform |
|---|---|
| EPS Est. (Current Period) | -0.08 |
| EPS Est. (Current Year) | -0.24 |
| Total Revenue | $32.00M |
| Net Income | $-0.92M |
| EPS | $-0.03 |
